TY  - JOUR
AU  - Franco, Fernando
AU  - Provencio, Mariano
PY  - 2018
TI  - Treatment of induction in resectable NSCLC with chemotherapy, followed by surgery and erlotinib
JF  - Annals of Translational Medicine; Vol 6, Supplement 1 (November 29, 2018): Annals of Translational Medicine
Y2  - 2018
KW  - 
N2  - We have carefully read the article by Dr. Cascone et al. in which they report the results of a phase 2 study evaluating the role of the induction therapy with cisplatin plus docetaxel, followed by a surgery and erlotinib in patients with resectable non-small cell lung cancer (NSCLC). This study has been registered as NCT00254384 and the data presented in the aforementioned article correspond to long-term efficacy results (1).
UR  - https://atm.amegroups.org/article/view/21443